Effectiveness of autologous blood injections (autohaemotherapy) in different states of acute respiratory tract infections: a randomised, double-blind placebo-controlled, multicentre study

2007 ◽  
Vol 12 ◽  
pp. 24-24
Author(s):  
PW Guendling ◽  
S Hensler ◽  
M Schmidt ◽  
E Mesenholl-Strehler ◽  
M Schmidt
Keyword(s):  
Respiratory Tract ◽  
Multicentre Study ◽  
Respiratory Tract Infections ◽  
Autologous Blood ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Acute Respiratory Tract Infections ◽  
Tract Infections

scholarly journals Use of OM-85 BV for the Prevention of Acute Respiratory Tract Infections in Occupational Medicine

2002 ◽  
Vol 30 (3) ◽  
pp. 325-329 ◽  
Author(s):  
MA Carmona-Ramírez ◽  
V Alvárez-Gómez ◽  
A Berber
Keyword(s):  
Respiratory Tract ◽  
Occupational Medicine ◽  
Respiratory Tract Infections ◽  
Controlled Clinical Trials ◽  
Factory Workers ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Acute Respiratory Tract Infections ◽  
Job Roles ◽  
Tract Infections

This study evaluated the safety and efficacy of the immunostimulatory agent OM-85 BV in 112 male car-factory workers who were highly susceptible to acute respiratory tract infections (ARTIs), each having experienced ≥ 4 ARTIs during 1999. From January to March 2000, each worker received one capsule of OM-85 BV (7 mg) per day for 10 consecutive days each month. The patients were followed for a further 9 months. Mean number of ARTIs decreased from 8.2 ± 2.1 per worker in 1999 to 5.3 ± 2.9 in 2000; i.e. a difference of −2.9 (95% confidence intervals, −3.5 to −2.4). Similar effects were observed in men who had different job roles, and no adverse events were reported during drug administration. We concluded that OM-85 BV appears to be safe and effective in reducing the incidence of ARTIs in susceptible workers, although further double-blind, placebo-controlled clinical trials are required.

A Placebo Controlled, Double-Blind Evaluation of Levamisole in the Reduction of the Frequency, Duration and Severity of Attacks in Children Suffering from Recurrent Upper Respiratory Tract Infections

1979 ◽  
Vol 7 (4) ◽  
pp. 302-304 ◽  
Author(s):  
F Dils
Keyword(s):  
Respiratory Tract ◽  
Respiratory Tract Infections ◽  
Controlled Study ◽  
Upper Respiratory Tract ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Single Body ◽  
Upper Respiratory ◽  
Tract Infections ◽  
Adjusted Dose

In a double-blind placebo controlled study of levamisole in the treatment of children with recurrent upper respiratory tract infection (URI) eighty-six patients took part. Medication was given once a week, in a single body-weight adjusted dose. The children treated with levamisole had a statistically significantly reduced incidence of episodes of infection which were less severe, less prolonged and required less antibiotics. No side-effects were reported.

Double-Blind Evaluation of Nimesulide vs Lysine-Aspirin in the Treatment of Paediatric Acute Respiratory Tract Infections

Drugs ◽  
1993 ◽  
Vol 46 (Supplement 1) ◽  
pp. 219-221 ◽  
Author(s):  
I. Barberi ◽  
A. Macchia ◽  
N. Spata ◽  
I. Scaricabarozzi ◽  
M.L. Nava
Keyword(s):  
Respiratory Tract ◽  
Respiratory Tract Infections ◽  
Double Blind ◽  
Acute Respiratory Tract Infections ◽  
Tract Infections
Sign in / Sign up

Export Citation Format

Share Document